Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Verification policies in Croatian medical biochemistry laboratories: a survey of the practice.
Milevoj Kopčinović L, Juričić G, Bokulić A, Vukasović I, Ćelap I, Čičak H, Kocijančić M, Miloš M, Lovrić M, Siter Kuprešanin M, Hrabrić Vlah S, Miletić M. Milevoj Kopčinović L, et al. Among authors: celap i. Biochem Med (Zagreb). 2022 Jun 15;32(2):020703. doi: 10.11613/BM.2022.020703. Epub 2022 Apr 15. Biochem Med (Zagreb). 2022. PMID: 35464743 Free PMC article.
Interference of M-protein on prothrombin time test - case report.
Margetić S, Ćelap I, Dukić L, Vukasović I, Virović-Jukić L. Margetić S, et al. Among authors: celap i. Biochem Med (Zagreb). 2016;26(2):248-54. doi: 10.11613/BM.2016.028. Biochem Med (Zagreb). 2016. PMID: 27346971 Free PMC article.
Precision, accuracy, cross reactivity and comparability of serum indices measurement on Abbott Architect c8000, Beckman Coulter AU5800 and Roche Cobas 6000 c501 clinical chemistry analyzers.
Nikolac Gabaj N, Miler M, Vrtarić A, Hemar M, Filipi P, Kocijančić M, Šupak Smolčić V, Ćelap I, Šimundić AM. Nikolac Gabaj N, et al. Among authors: celap i. Clin Chem Lab Med. 2018 Apr 25;56(5):776-788. doi: 10.1515/cclm-2017-0889. Clin Chem Lab Med. 2018. PMID: 29315074
Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations.
Margetić S, Ćelap I, Delić Brkljačić D, Pavlović N, Šupraha Goreta S, Kobasić I, Lovrenčić-Huzjan A, Bašić Kes V. Margetić S, et al. Among authors: celap i. Biochem Med (Zagreb). 2020 Feb 15;30(1):010702. doi: 10.11613/BM.2020.010702. Epub 2019 Dec 15. Biochem Med (Zagreb). 2020. PMID: 31839722 Free PMC article.
39 results